Introduction In the rapidly evolving landscape of cancer treatment, theranostic biomarkers emerge as pivotal tools that bridge the gap between diagnosis and personalized therapy. These biomarkers not ...
<h2 id="introduction">Introduction</h2> <p>In the rapidly evolving landscape of cancer treatment, theranostic biomarkers emerge as pivotal tools that bridge the gap between diagnosis and personalized therapy. These biomarkers not only provide critical insights into tumor characteristics but also guide treatment decisions, ultimately enhancing patient outcomes across various cancer types.</p> <p>However, with numerous biomarkers available, how can clinicians effectively navigate this complex terrain to optimize treatment strategies?</p> <p>This article delves into ten key theranostic biomarkers, exploring their definitions, significance, and the latest advancements that are shaping the future of oncology.</p> <h2 id="bioaccess-defining-her-2-neu-as-a-theranostic-biomarker-in-breast-cancer">bioaccess®: Defining HER2/neu as a Theranostic Biomarker in Breast Cancer</h2> <p>HER2/neu is a protein whose…